Identification of ACE-inhibitory peptides in salt-free soy sauce that are transportable across caco-2 cell monolayers

Anand, 2003, Interactions of the dipeptide ester prodrugs of acyclovir with the intestinal oligopeptide transporter: competitive inhibition of glycylsarcosine transport in human intestinal cell line-caco-2, J Pharmacol Exp Ther, 304, 781, 10.1124/jpet.102.044313 Ariyoshi, 1993, Angiotensin converting enzyme inhibitors derived from food proteins, Trends Food Sci Technol, 4, 139, 10.1016/0924-2244(93)90033-7 Bailey, 2000, How to make drugs orally active: a substrate template for peptide transporter PepT1, Angew Chem Int Ed Engl, 39, 505, 10.1002/(SICI)1521-3773(20000204)39:3<505::AID-ANIE505>3.0.CO;2-B Behrens, 2003, Do cell culture conditions influence the carrier-mediated transport of peptides in caco-2 cell monolayers?, Eur J Pharm Sci, 19, 433, 10.1016/S0928-0987(03)00146-5 Briske-Anderson, 1997, The influence of culture time and passage number on the morphological and physiological development of Caco-2 cells, Proc Soc Exp Biol Med, 214, 248, 10.3181/00379727-214-44093 Cheng, 1999, Intestinal peptide transport systems and oral drug availability, Pharm Res, 16, 1331, 10.1023/A:1018982505021 Chobanian, 2000, National Heart Lung and Blood Institute Workshop on sodium and blood pressure: a critical review of current scientific evidence, Hypertension, 35, 858, 10.1161/01.HYP.35.4.858 Clare, 2000, Bioactive milk peptides: a prospectus, J Dairy Sci, 83, 1187, 10.3168/jds.S0022-0302(00)74983-6 2001 Kinoshita, 1993, Purification and identification of an angiotensin I-converting enzyme inhibitor from soy sauce, Biosci Biotechnol Biochem, 57, 1107, 10.1271/bbb.57.1107 Kuboda K, Noda Y. Japanese Patent 2964370 1999. Lin, 1999, Competitive inhibition of glycylsarcosine transport by enalapril in rabbit renal brush border membrane vesicle, Pharm Res, 16, 609, 10.1023/A:1018847818766 Matsui, 2004, Tissue distribution of antihypertensive dipeptide, Val-Tyr, after its single oral administration to spontaneously hypertensive rats, J Pept Sci, 10, 535, 10.1002/psc.568 Matsui, 2006, Antihypertensive peptide from nature resources, 259 Matsui, 2002, Val-Tyr as a natural antihypertensive dipeptide can be absorbed into human circulatory blood system, Clin Exp Pharmacol Physiol, 29, 204, 10.1046/j.1440-1681.2002.03628.x Matsui, 2006, Combined administration of captopril with an antihypertensive Val-Tyr di-peptide to spontaneously hypertensive rats attenuates the blood pressure lowering effect, Life Sci, 79, 2492, 10.1016/j.lfs.2006.08.013 Matsui, 2002, Gastrointestinal enzyme production of bioactive peptides from royal jelly protein and their antihypertensive ability in SHR, J Nutr Biochem, 13, 80, 10.1016/S0955-2863(01)00198-X Menon, 2003, Comparison of ceftibuten transport across Caco-2 cells and rat jejunum mounted on modified Ussing chamber, Biopharm Drug Disp, 24, 299, 10.1002/bdd.366 Meredith, 2000, Modified amino acids and peptides as substrates for the intestinal peptide transporter PepT1, Eur J Biochem, 267, 3723, 10.1046/j.1432-1327.2000.01405.x Satake, 2002, Transepithelial transport of the bioactive tripeptide, Val-Pro-Pro, in human intestinal Caco-2 cell monolayers, Biosci Biotechnol Biochem, 66, 378, 10.1271/bbb.66.378 Shin, 2001, An angiotensin I converting enzyme inhibitory peptide derived from Korean soybean paste, exerts antihypertensive activity in vivo, J Agric Food Chem, 49, 3004, 10.1021/jf001135r Schlimme, 1995, Bioactive peptides derived from milk protein. Structural, physiological and analytical aspects, Die Nahrung, 39, 1, 10.1002/food.19950390102 Scientific Advisory Committee on Nutrition: Salt and Health. SACN/SaltSub/03/02 2003, p. 1–34. Siamak, 1971, Intestinal transport of dipeptides in man: relative importance of hydrolysis and intact absorption, J Clin Invest, 50, 2266, 10.1172/JCI106724 Siamak, 1974, Functional characterization of dipeptide transport system in human jejunum, J Clin Invest, 53, 1368, 10.1172/JCI107685 Steijns, 1996, Dietary proteins as the source of new health promoting bio-active peptides with special attention to glutamine peptide, Food Technol Eur, 80 Tsuda, 2006, Transport characteristics of a novel peptide transporter 1 substrate, antihypotensive drug midodrine, and its amino acid derivatives, J Pharmacol Exp Ther, 318, 455, 10.1124/jpet.106.102830 Watanabe, 2006, A miso (Japanese soybean paste) diet conferred greater protection against hypertension than a sodium chloride diet in Dahl salt-sensitive rats, Hypertens Res, 29, 731, 10.1291/hypres.29.731 Wu, 2002, Characterization of inhibition and stability of soy-protein-derived angiotensin I-converting enzyme inhibitory peptides, Food Res Int, 35, 367, 10.1016/S0963-9969(01)00131-4 Wu, 2001, Hypotensive and physiological effect of angiotensin converting enzyme inhibitory peptides derived from soy protein on spontaneously hypertensive rats, J Agric Food Chem, 49, 501, 10.1021/jf000695n Zhu, 2000, Differential recognition of ACE inhibitors in Xenopus lavevis oocytes expressing rat PEPT1 and PEPT2, Pharm Res, 17, 526, 10.1023/A:1007556630189